Expanding the Targets of Renal Sympathetic Denervation: From Resistant Hypertension to Atrial Fibrillation

Journal of Hypertension- Open Access

doi 10.4172/2167-1095.1000123

Full Text

Abstract

Available in

Date

Authors

Publisher

OMICS Publishing Group

Related search

Renal Sympathetic Denervation Versus Antiarrhythmic Drugs for Drug-Resistant Hypertension and Symptomatic Atrial Fibrillation (RSDforAF) Trial: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2013English

Renal Sympathetic Denervation Provides Ventricular Rate Control but Does Not Prevent Atrial Electrical Remodeling During Atrial Fibrillation

Hypertension
Internal Medicine
2013English

CONGRESS COVERAGE: Renal Sympathetic Denervation for Resistant Hypertension: Symplicity HTN-3 and the Power of Placebo

Open Hypertension Journal
Cardiovascular MedicineCardiology
2014English

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Catheter-Based Renal Sympathetic Denervation Significantly Inhibits Atrial Fibrillation Induced by Electrical Stimulation of the Left Stellate Ganglion and Rapid Atrial Pacing

PLoS ONE
Multidisciplinary
2013English

Response to Letter Regarding Article, "Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

A Controlled Trial of Renal Denervation for Resistant Hypertension

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

Renal Denervation for Resistant Hypertension—the Symplicity HTN-1 Study

The Lancet
Medicine
2014English

Renal Sympathetic Denervation: Renal Nerve Stimulation

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy